Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

445 indexed citations
published 2011

Countries where authors are citing Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

Specialization
Citations

This map shows the geographic impact of Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy more than expected).

Fields of papers citing Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy.

About Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

This paper, published in 2011, received 445 indexed citations . Written by Hongting Zheng, Samantha A. Whitman, Wei Wu, Georg T. Wondrak, Pak Kin Wong, Deyu Fang and Donna D. Zhang covering the research area of Molecular Biology, Biochemistry and Pathology and Forensic Medicine. It is primarily cited by scholars working on Molecular Biology (278 citations), Endocrinology, Diabetes and Metabolism (83 citations) and Clinical Biochemistry (74 citations). Published in Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.2337/db11-0807.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026